Mark Holliday
- Physiology top 5%
- Asthma and respiratory diseases 21
-
- Respiratory and Cough-Related Research 17
- Inhalation and Respiratory Drug Delivery 9
- Immunology and Allergy top 10%
- Allergic Rhinitis and Sensitization 3
- Surgery top 10%
- Pancreatitis Pathology and Treatment 5
- Orthopaedic implants and arthroplasty 2
- Gastrointestinal disorders and treatments 2
-
- Pancreatic and Hepatic Oncology Research 3
Mark Holliday
31 papers receiving 997 citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Critical Care and Intensive Care Medicine 117
- Physiology 448
- Pulmonary and Respiratory Medicine 487
- Immunology and Allergy 47
- Surgery 334
Countries citing papers authored by Mark Holliday
This map shows the geographic impact of Mark Holliday's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Holliday with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Holliday more than expected).
Fields of papers citing papers by Mark Holliday
This network shows the impact of papers produced by Mark Holliday. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Holliday. The network helps show where Mark Holliday may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Holliday, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 10 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 9 | |
| 5 | 2021 | 20 | |
| 6 | 2020 | 45 | |
| 7 | 2020 | 14 | |
| 8 | 2020 | 7 | |
| 9 | 2020 | 26 | |
| 10 | 2020 | 16 | |
| 11 | Combination budesonide/formoterol inhaler as sole reliever therapy in Māori and Pacific people with mild and moderate asthma. | 2020 | 5 |
| 12 | Controlled Trial of Budesonide–Formoterol as Needed for Mild Asthmabreakdown → | 2019 | 266 |
| 13 | 2017 | 13 | |
| 14 | 2017 | 5 | |
| 15 | 2017 | 10 | |
| 16 | 2015 | 27 | |
| 17 | 2015 | 132 | |
| 18 | 1992 | 181 | |
| 19 | 1989 | 8 | |
| 20 | 1983 | 5 |
About Mark Holliday
Mark Holliday is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy, having authored 32 papers that have together received 1.0k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (21 papers), Respiratory and Cough-Related Research (17 papers), Inhalation and Respiratory Drug Delivery (9 papers), Pancreatitis Pathology and Treatment (5 papers), Allergic Rhinitis and Sensitization (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Orthopaedic implants and arthroplasty (2 papers) and Gastrointestinal disorders and treatments (2 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (117 citations), Physiology (448 citations) and Pulmonary and Respiratory Medicine (487 citations). Mark Holliday has collaborated with scholars based in New Zealand, United Kingdom and Australia. Frequent co-authors include T Leese, Richard Beasley, Mark Weatherall, Irene Braithwaite, R A Swann, Andrew Exley, J. Cohen, Helen K. Reddel, Robert J. Hancox and Ian Pavord. Their work appears in journals such as BMJ Open, BMJ Open Respiratory Research, European Respiratory Journal, ERJ Open Research and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.